ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada.
Promis Neurosciences stock last closed at $0.42, down 1.19% from the previous day, and has decreased 67.32% in one year. It has underperformed other stocks in the Biotechnology industry by 0.47 percentage points. Promis Neurosciences stock is currently +9.21% from its 52-week low of $0.38, and -73.9% from its 52-week high of $1.59.
As of Oct 31, 2025, there are 51.81M shares of PMN outstanding. The market cap of PMN is $21.50M. In the last 24 hours, 343,000 PMN shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy PMN shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, the next step is to fill out some personal details so you are able to invest in PMN today.
Now that you've finished signing up on stock market apps, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your new investment account.
After you have identified the best place to buy Promis Neurosciences stock, it's absolutely critical to research their stock before you invest, so you truly wrap your head around the risk and upside.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on PMN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PMN's fair value.
You can do additional valuation research on PMN's stock here.
Out of 2 sell side analysts who monitor PMN, the consensus analyst rating on Promis Neurosciences is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Promis Neurosciences stock forecast page.
In the past year, insiders at PMN have bought more shares than they have sold.
Max A. Milbury, was the latest PMN insider to buy. They bought $14,922.47 worth of PMN stock on Oct 3, 2025.
Get more info about who owns PMN shares here.
No, Promis Neurosciences doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary order types:
Press the Open Trade button and your broker will execute the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Now that you own some PMN shares, you'll want to keep up with your new shares.
Make a watchlist to see the latest developments about your PMN stock.
To reiterate, here are the 6 steps for buying Promis Neurosciences stock:
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Promis Neurosciences, hit the button below to create your watchlist.